THE V122I MUTATION IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IS SIGNIFICANTLY ASSOCIATED WITH AN INCREASED INCIDENCE OF POLYNEUROPATHY

被引：0
|
作者：
Parker, Margaret
Damrauer, Scott
Erbe, David
Aldinc, Emre
Ticau, Simina
Flynn-Caroll, Alexander
Deaton, Aimee
Ward, Lucas
Rader, Daniel
Fitzgerald, Kevin
Vaishnaw, Akshay
Hinkle, Gregory
Nioi, Paul
机构：
来源：
MUSCLE & NERVE | 2020年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
198
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [31] Homozygosity for the V122I Mutation in Transthyretin Is Associated with Earlier Onset of Cardiac Amyloidosis in the African American Population in the Seventh Decade of Life
    Reddi, Honey V.
    Jenkins, Sarah
    Theis, Jason
    Thomas, Brittany C.
    Connors, Lawreen H.
    Van Rhee, Frits
    Highsmith, W. Edward, Jr.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (01): : 68 - 74
  • [32] Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
    Obici, Laura
    Ajroud-Driss, Senda
    Lin, Kon-Ping
    Berk, John L.
    Gillmore, Julian D.
    Kale, Parag
    Koike, Haruki
    Danese, David
    Aldinc, Emre
    Chen, Chongshu
    Vest, John
    Adams, David
    NEUROLOGY AND THERAPY, 2023, 12 (05) : 1759 - 1775
  • [33] Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Labeyrie, Celine
    Merkel, Madeline
    Sethi, Sakshi
    Popadic, Lyuba
    Yang, Hongbo
    Sweetser, Marianne T.
    Lin, Hollis
    Adams, David
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (09)
  • [34] VARIABLE PRESENTATION OF HOMOZYGOSITY FOR THE V122I MUTATION IN TRANSTHYRETIN IN TWO BROTHERS
    Lowell, Andrew
    Lessen, Samantha
    Gruber, Dorota
    Stern, David Lee
    Azari, Bani Mekisha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3556 - 3556
  • [35] LONGTERM TREATMENT EFFECTS OF INOTERSEN ON QUALITY OF LIFE IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Brown, Duncan
    Karam, Chafic
    Yang, Min
    Done, Nicolae
    Zhu, JingJing
    Greatsinger, Ali
    Bozas, Ana
    Llonch, Montserrat Vera
    Signorovitch, James
    MUSCLE & NERVE, 2021, 64 : S57 - S57
  • [36] Long-term Integrated Safety of Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
    Gillmore, Julian
    Berk, John
    Dispenzieri, Angela
    Polydefkis, Michael
    Gonzalez-Duarte, Alejandra
    Sekijima, Yoshiki
    Sweetser, Marianne T.
    Arum, Seth
    Wang, Jing Jing
    White, Matthew T.
    Maurer, Mathew
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S67 - S68
  • [37] IDENTIFYING MIXED PHENOTYPE: EVALUATING THE PRESENCE OF POLYNEUROPATHY IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY
    Grogan, Martha
    Hawkins, Philip
    Kristen, Arnt
    Berk, John
    Suhr, Ole B.
    Lin, Hollis
    Merkel, Madeline
    McManus, Anastasia
    Powell, Christine
    Vest, John
    Karsten, Verena
    Judge, Daniel
    MUSCLE & NERVE, 2020, 62 : S107 - S107
  • [38] Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy
    Merkel, Madeline
    Grogan, Martha
    Hawkins, Philip N.
    Kristen, Arnt V.
    Berk, John L.
    Suhr, Ole B.
    Lin, Hollis
    McManus, Anastasia
    Powell, Christine
    Vest, John
    Karsten, Verena
    Judge, Daniel P.
    NEUROLOGY, 2020, 94 (15)
  • [39] Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
    Adams, David
    Tournev, Ivailo L.
    Taylor, Mark S.
    Coelho, Teresa
    Plante-Bordeneuve, Violaine
    Berk, John L.
    Gonzalez-Duarte, Alejandra
    Gillmore, Julian D.
    Low, Soon-Chai
    Sekijima, Yoshiki
    Obici, Laura
    Chen, Chongshu
    Badri, Prajakta
    Arum, Seth M.
    Vest, John
    Polydefkis, Michael
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2023, 30 (01): : 18 - 26
  • [40] Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Gillmore, J.
    Berk, J.
    Dispenzieri, A.
    Polydefkis, M.
    Gonzalez-Duarte, A.
    Sekijima, Y.
    Sweetser, M. T.
    Arum, S.
    Wang, J. J.
    White, M. T.
    Maurer, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2129 - 2129
12345